Altered Pulmonary Lymphatic Development in Infants with Chronic Lung Disease

Table 1

Clinical variables of controls and infants with CLD.

	Controls		CLD*
	Qualitative	Quantitative
Number	9	4	9
Gestational age, weeks	31±6^a	31±4	26±2
Postmenstrual age (PMA)	NA	NA	30±2
Birth weight, kg	1.926±1.2	1.474±0.894	0.819±0.222
Ventilator days	1.6±1.0	1.7±1.3	29.6±19
Days lived	1.6±1.0	1.7±1.3	30±16
% antenatal steroids	11	0	42
% surfactant	33	50	71
% RDS (moderate to severe)	0	0	71
% postnatal steroids	11	0	71
Cause of death
Respiratory failure	0	0	3
Extreme immaturity (died in DR)	1	0	0
Intracranial hemorrhage, grade IV	1	0	0
NEC	0	0	2
DIC/other hemorrhage	2	1	1
HIE/encephalomalacia	3	2	0
Sepsis/pneumonia	1	1	1
Other	1	0	2

aAverage ± standard deviation.
*Complete clinical data available for 7 CLD infants.